Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT06582017 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Nammi Therapeutics Inc |
| Last Updated on CT.gov | August 27, 2026 (Aug 27, 2026) |
As of October 12, 2026: Clinical trial NCT06582017 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Nammi Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06582017 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06582017 was last updated Aug 27, 2026 (August 27, 2026). HelloStudys verifies this status automatically.